Phase 2 Stroke Trial, Recruiting (NCT06968663)

Phase 2 Stroke Trial, Recruiting NCT06968663 Sponsor: University of Pennsylvania Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT06968663 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had a stroke on the left side of the brain that has caused difficulty with language (aphasia)
People whose stroke happened between 2 and 6 weeks before joining the trial
People who are able to understand what the study involves and agree to take part
People who speak and understand English
People who are right-handed

Who may not be able to join:

People with a history of serious or ongoing substance abuse problems
People who have previously had a head injury that caused them to be unconscious for more than 5 minutes
People with a history of major mental health conditions
People who have dementia or other conditions affecting the brain or nervous system
People who have epilepsy or who have had a seizure after their stroke
People who have a pacemaker (a device implanted in the chest to help control heartbeat)
People who have been diagnosed with tinnitus (ringing or buzzing in the ears)
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: H. Branch Coslett, MD, University of Pennsylvania

Phone: 215-964-2502

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06968663

Sponsor: University of Pennsylvania

Phase: Phase 2

Status: Recruiting

Condition: Stroke

Trial contact: 215-964-2502

More information: https://clinicaltrials.gov/study/NCT06968663

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had a stroke on the left side of the brain that has caused difficulty with language (aphasia)
People whose stroke happened between 2 and 6 weeks before joining the trial
People who are able to understand what the study involves and agree to take part
People who speak and understand English
People who are right-handed

Who may not be able to join:

People with a history of serious or ongoing substance abuse problems
People who have previously had a head injury that caused them to be unconscious for more than 5 minutes
People with a history of major mental health conditions
People who have dementia or other conditions affecting the brain or nervous system
People who have epilepsy or who have had a seizure after their stroke
People who have a pacemaker (a device implanted in the chest to help control heartbeat)
People who have been diagnosed with tinnitus (ringing or buzzing in the ears)
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

University of Pennsylvania

Registry

ClinicalTrials.gov

Start date

1 August 2024

Est. completion

31 July 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Overall language function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov